ATE267263T1 - Eukaryotische genexpressionskassette und deren verwendungen - Google Patents
Eukaryotische genexpressionskassette und deren verwendungenInfo
- Publication number
- ATE267263T1 ATE267263T1 AT98900570T AT98900570T ATE267263T1 AT E267263 T1 ATE267263 T1 AT E267263T1 AT 98900570 T AT98900570 T AT 98900570T AT 98900570 T AT98900570 T AT 98900570T AT E267263 T1 ATE267263 T1 AT E267263T1
- Authority
- AT
- Austria
- Prior art keywords
- expression cassette
- gene expression
- eukaryotic gene
- herpes simplex
- simplex virus
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 4
- 241000700584 Simplexvirus Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000007774 longterm Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 230000007733 viral latency Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700411.3A GB9700411D0 (en) | 1997-01-10 | 1997-01-10 | Eukaryotic gene expression cassette and uses thereof |
| PCT/GB1998/000074 WO1998030707A2 (en) | 1997-01-10 | 1998-01-12 | Eukaryotic gene expression cassette and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267263T1 true ATE267263T1 (de) | 2004-06-15 |
Family
ID=10805768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98900570T ATE267263T1 (de) | 1997-01-10 | 1998-01-12 | Eukaryotische genexpressionskassette und deren verwendungen |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP1441033A3 (de) |
| JP (1) | JP2001508294A (de) |
| KR (1) | KR100507399B1 (de) |
| CN (1) | CN1231589C (de) |
| AT (1) | ATE267263T1 (de) |
| AU (1) | AU749064B2 (de) |
| BR (1) | BR9806866A (de) |
| CA (1) | CA2278326A1 (de) |
| DE (1) | DE69824027T2 (de) |
| DK (1) | DK1021553T3 (de) |
| ES (1) | ES2221980T3 (de) |
| GB (1) | GB9700411D0 (de) |
| IL (2) | IL130876A0 (de) |
| PT (1) | PT1021553E (de) |
| WO (1) | WO1998030707A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9801930D0 (en) | 1998-01-29 | 1998-03-25 | Univ London | Mutant herpes simplex viruses and uses thereof |
| GB9807865D0 (en) * | 1998-04-09 | 1998-06-10 | Univ London | Herpes simplex virus latency associated transcript polypeptides |
| US6713067B2 (en) | 1998-07-31 | 2004-03-30 | Biovex Limited | Herpes viruses for immune modulation |
| JP2002523024A (ja) * | 1998-07-31 | 2002-07-30 | ケンブリッジ ユニバーシティ テクニカル サービシズ リミティド | ヘルペスウイルスの潜伏活性調節配列及び遺伝子運搬のための潜伏不活性ヘルペスウイルス |
| GB9930418D0 (en) * | 1999-12-22 | 2000-02-16 | Neurovex Ltd | Replication incompetent herpes virus vectors |
| US7063851B2 (en) | 2000-04-12 | 2006-06-20 | Biovex Limited | Herpes viruses for immune modulation |
| CA2422748C (en) | 2000-09-21 | 2011-08-09 | Dsm N.V. | Talaromyces xylanases |
| AUPR518501A0 (en) | 2001-05-22 | 2001-06-14 | Unisearch Limited | Yin yang-1 |
| TWI328612B (en) | 2002-07-25 | 2010-08-11 | Dsm Ip Assets Bv | Genes and their encoded polypeptides involved in the biosynthetic pathway of vitamin b12, vectors and host cells comprising the genes, and process for producing vitamin b12 |
| US20050272030A1 (en) * | 2002-09-27 | 2005-12-08 | Powder Ject Research Limited | Nucleic acid constructs for gene expression |
| GB0317511D0 (en) | 2003-07-25 | 2003-08-27 | Biovex Ltd | Viral vectors |
| WO2005080581A2 (en) | 2004-02-17 | 2005-09-01 | University Of Florida Research Foundation, Inc. | Insulated herpesvirus-derived gene expression cassettes for sustained and regulatable gene expression |
| WO2011130749A2 (en) | 2010-04-16 | 2011-10-20 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors |
| CA2918535A1 (en) * | 2013-07-17 | 2015-01-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Non-toxic hsv vectors for efficient gene delivery applications and complementing cells for their production |
| WO2015066042A1 (en) | 2013-10-28 | 2015-05-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Oncolytic hsv vector |
| DK3400293T4 (da) | 2016-01-08 | 2023-08-28 | Replimune Ltd | Modificeret onkolytisk virus |
| DK3408382T3 (da) | 2016-01-27 | 2022-06-20 | Oncorus Inc | Onkolytiske virale vektorer og anvendelser deraf |
| GB201700350D0 (en) * | 2017-01-09 | 2017-02-22 | Replimune Ltd | Altered virus |
| AU2018306455A1 (en) | 2017-07-26 | 2020-02-27 | Virogin Biotech Canada Ltd | Oncolytic viral vectors and uses thereof |
| CA3142194A1 (en) * | 2019-05-30 | 2020-12-03 | Solid Biosciences Inc. | Recombinant herpesvirales vector |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849571A (en) * | 1990-10-10 | 1998-12-15 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Latency active herpes virus promoters and their use |
| PT566554E (pt) * | 1992-03-13 | 2000-09-29 | Monsanto Co | Producao de proteinas recombinantes usando promotores do virus de herpes e transactivadores vp16 |
-
1997
- 1997-01-10 GB GBGB9700411.3A patent/GB9700411D0/en active Pending
-
1998
- 1998-01-12 ES ES98900570T patent/ES2221980T3/es not_active Expired - Lifetime
- 1998-01-12 IL IL13087698A patent/IL130876A0/xx not_active IP Right Cessation
- 1998-01-12 PT PT98900570T patent/PT1021553E/pt unknown
- 1998-01-12 CN CNB988032147A patent/CN1231589C/zh not_active Expired - Fee Related
- 1998-01-12 EP EP04008341A patent/EP1441033A3/de not_active Withdrawn
- 1998-01-12 BR BR9806866-0A patent/BR9806866A/pt not_active Application Discontinuation
- 1998-01-12 JP JP53066398A patent/JP2001508294A/ja not_active Ceased
- 1998-01-12 DK DK98900570T patent/DK1021553T3/da active
- 1998-01-12 AU AU55669/98A patent/AU749064B2/en not_active Ceased
- 1998-01-12 CA CA002278326A patent/CA2278326A1/en not_active Abandoned
- 1998-01-12 WO PCT/GB1998/000074 patent/WO1998030707A2/en not_active Ceased
- 1998-01-12 EP EP98900570A patent/EP1021553B1/de not_active Expired - Lifetime
- 1998-01-12 KR KR10-1999-7006256A patent/KR100507399B1/ko not_active Expired - Fee Related
- 1998-01-12 DE DE69824027T patent/DE69824027T2/de not_active Expired - Lifetime
- 1998-01-12 AT AT98900570T patent/ATE267263T1/de not_active IP Right Cessation
-
1999
- 1999-07-09 IL IL130876A patent/IL130876A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1441033A2 (de) | 2004-07-28 |
| CN1231589C (zh) | 2005-12-14 |
| DK1021553T3 (da) | 2004-09-27 |
| GB9700411D0 (en) | 1997-02-26 |
| EP1021553B1 (de) | 2004-05-19 |
| DE69824027T2 (de) | 2004-10-28 |
| JP2001508294A (ja) | 2001-06-26 |
| EP1441033A3 (de) | 2004-12-01 |
| CN1250480A (zh) | 2000-04-12 |
| IL130876A (en) | 2006-08-20 |
| PT1021553E (pt) | 2004-09-30 |
| ES2221980T3 (es) | 2005-01-16 |
| CA2278326A1 (en) | 1998-07-16 |
| DE69824027D1 (de) | 2004-06-24 |
| AU5566998A (en) | 1998-08-03 |
| AU749064B2 (en) | 2002-06-20 |
| WO1998030707A3 (en) | 1998-09-11 |
| BR9806866A (pt) | 2000-04-18 |
| EP1021553A2 (de) | 2000-07-26 |
| KR20000070037A (ko) | 2000-11-25 |
| KR100507399B1 (ko) | 2005-08-10 |
| WO1998030707A2 (en) | 1998-07-16 |
| IL130876A0 (en) | 2001-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE267263T1 (de) | Eukaryotische genexpressionskassette und deren verwendungen | |
| NO303831B1 (no) | Isolert DNA-sekvens, vektor, vertscelle, polypeptid og anvendelse in vitro av polypeptidet ved en fremgangsmÕte for transfeksjon av hematopoeseceller med eksogen DNA | |
| MX9800719A (es) | Proteinas de transporte y sus usos. | |
| ES2150894T1 (es) | Vector de baculovirus modificado por proteinas de envoltura para terapia genica. | |
| ATE321869T1 (de) | Fusionproteine für intra- und interzelluläre transport und deren verwendungen | |
| AU3675095A (en) | Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell | |
| ES2164260T3 (es) | Vectores virales para la terapia genica. | |
| ZA957797B (en) | Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell | |
| IE842210L (en) | Vaccine | |
| DK1137768T3 (da) | Human hybrid værtscelle til pattedyrgenekspression | |
| GB8718779D0 (en) | Dna sequence & expression vector | |
| AU1278695A (en) | Homologous recombination antibody expression system for murine cells | |
| BR9711998A (pt) | Herpesvìrus saimiri como vetor viral. | |
| AU5318496A (en) | Adenovirus vectors for gene therapy | |
| WO2002014527A3 (en) | Gp64-null baculoviruses pseudotyped with heterologous envelope proteins | |
| EP0837931A4 (de) | Methode zur expression in und isolation von biologisch aktiven molekülen aus urin | |
| SI1212428T1 (en) | Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression | |
| AU582288B2 (en) | Vector and method for achieving high level expression in eukaryotic cells | |
| AU1814995A (en) | Galanin receptor, nucleic acids, transformed cells and uses thereof | |
| EP0774513A4 (de) | REKOMBINANTES HERPESVIRUS UNTER DER VERWENDUNG DES gB GENPROMOTERS | |
| AU2233297A (en) | Promoter | |
| WO1999027123A3 (en) | Modified sv40 viral vectors | |
| ES8606402A1 (es) | Un procedimiento para preparar una molecula de adn recom- biante | |
| PT1032418E (pt) | Replicoes compactos do virus epstein-barr | |
| CA2301874A1 (en) | Suppression of malignancy utilizing ribonucleotide reductase r1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1021553 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |